The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Tarih
2012
Yazar
Khunti, K.
Karnieli, E.
Liebl, A.
Ligthelm, R. J.
Nazeri, A.
Orozco-Beltran, D.
Pan, C.
Ross, S. A.
Svendsen, A. L.
Vora, J.
Yale, J. -F.
Meneghini, L. F.
Damci, T.
Caputo, S.
Dzida, G. J.
Ji, Q.
Kaiser, M.
Üst veri
Tüm öğe kaydını göster
Özet
Aims: Evaluate the safety and efficacy of once-daily insulin detemir initiated in routine clinical practice in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycaemic agents (OHAs).
Bağlantı
http://hdl.handle.net/20.500.12627/45051
https://doi.org/10.1111/j.1463-1326.2012.01665.x
Koleksiyonlar